Abstract
Toxicological testing in animals is relied upon as a surrogate for clinical testing of most food additives. Both animal and human clinical test results are generally available for direct additives when high levels of exposure are expected. Limited animal studies or in vitro test results may be the only sources of toxicological data available when low levels of exposure (μg/person/day) are expected and where no effects of the additive on the food itself are desired. Safety assessment of such materials for humans requires mathematical extrapolation from any effects observed in test animals to arrive at acceptable daily intakes (ADIs) for humans. Models of anatomy may be used to estimate tissue and organ weights where that information is missing and necessary for evaluation of a data set. The effect of growth on target tissue exposure during critical phases of organ development can be more accurately assessed when models of growth and known physiological changes are combined with pharmacokinetic results for test species. Kinetic models, when combined with limited chemical property, kinetic, and distribution data, can often be used to predict steady-state plasma and tissue levels of a test material over the range of doses employed in chronic studies to aid in interpretation of effects that are often nonlinear with respect to delivered dose. A better understanding of the reasons for nonlinearity of effects in animals improves our confidence in extrapolation to humans.
Similar content being viewed by others
References
Code of Federal Regulations. 21 CFR 170.3. Washington, DC: US Government Printing Office; 2002.
Code of Federal Regulations. 21 CFR 172-177. Washington, DC: US Government Printing Office; 2002.
Code of Federal Regulations. 21 CFR 170.22. Washington, DC: US Government Printing Office; 2002.
Dourson ML, Stara JF. Regulatory history and experimental support of uncertainty (safety) factors.Regul Toxicol Pharmacol. 1983;3:224–238.
Roth WL, Young JF. Use of pharmacokinetic data under the FDA's Redbook II guidelines for direct food additives.Int J Toxicol. 1998;17:355–381.
Roth WL, Freeman RA, Wilson AGE. A physiologically based model for gastrointestinal absorption and excretion of chemicals carried by lipidsRisk Anal. 1993;13:531–543.
Roth WL, Garthoff LH, Luecke RH, Young JF. Standardized growth models of experimental animals for reconstruction of whole animal pharmacokinetics.Proceedings of 10th International Conference on Mechanics in Medicine and Biology March 2–5, 1998. Honolulu, Hawaii.
Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. Physiological parameter values for physiologically based pharmacokinetic models.Toxicol Ind Health. 1997;13:407–484.
Deavers S, Huggins RA, Smith EL. Absolute and relative organ weights of the growing beagle.Growth. 1972;36:195–208.
Luecke RH, Wosilait WD, Young JF. Mathematical representation of organ growth in the human embryo/fetus.Int J Biomed Comput. 1995;39:337–347.
Luecke RH, Wosilait WD, Young JF. Mathematical analysis for teratogenic sensitivity.Teratology: 1997;55:373–380.
Murray WW. Biological significance of factors influencing the incidence of mammary cancer in mice.J Natl Cancer Inst. 1964;34:21–41.
Ross M. Length of life and nutrition in the rat.J Nutr. 1961;75:197–210.
Druckrey V, Schildbach A, Schmähl D. Quantitative analyse der carcinogenen wirkung von diäthylnitosamin.Arzniemittel Forsch. 1963;13:841–851.
Rozman KK. Delayed acute toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD), after oral administration, obeys Haber's rule of inhalation toxicology.Toxicol Sci. 1999;49:102–109.
Wasserman LR, Yoh TF, Rashkoff IA. Blood volumes in human subjects as determined by P32 labeling of erythrocytes.J Lab. Clin Med. 1951;37:342–352.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: September 22, 2005
Rights and permissions
About this article
Cite this article
Roth, W.L. Use of anatomical and kinetic models in the evaluation of human food additive safety. AAPS J 7, 31 (2005). https://doi.org/10.1208/aapsj070231
Received:
Accepted:
DOI: https://doi.org/10.1208/aapsj070231